Public Calendar: November 12-18, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 11/13/2023
Location: Silver Spring, MD
Subject: Integrated Food Safety System
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Adriane Casalotti, Chelsea Gridley-Smith, Jennifer Li, Lori Tremmel Freeman, Nicole Silverman (The National Association of County and City Health Officials);

Event Date: 11/14/2023
Location: Virtual
Subject: Reagan-Udall Foundation - Integrating Clinical Studies into Health Care Delivery: Post-Market Evidence Generation for Medical Products
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered guests

Event Date: 11/14/2023
Location: Washington, DC
Subject: Friends of Cancer Research Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, media and other registered guests

Event Date: 11/15/2023
Location: Virtual
Subject: Association of Professors of Medicine Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia

Event Date: 11/15/2023
Location: Washington, DC
Subject: Healthcare Distribution Alliance Board of Directors Meeting
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Several members of the Healthcare Distribution Alliance Board of Directors and staff

Event Date: 11/16/2023
Location: Virtual
Subject: Reagan-Udall Foundation - Front-of-Package Nutrition Labeling
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 11/16/2023
Location: Virtual
Subject: National Academy of Medicine - Shaping the Next 10 Years in Data Sharing: Building on the Gains Made and Looking Ahead to the Next 10 Years in Advancing Human Health
FDA Participant/Group: ELENI ANAGNOSTIADIS;
Non FDA Participant/Group: Industry, academia, government, and other invited attendees

Event Date: 11/17/2023
Location: Durham, NC
Subject: Duke University School of Medicine National Forum on Best Practices to Address Health Misinformation
FDA Participant/Group: HAIDER WARRAICH;
Non FDA Participant/Group: Academia and other invited attendees

Event Date: 11/17/2023
Location: Virtual
Subject: Generic Drug Testing Program
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Andrew Bindman, Anthony Barrueta, Mary Beth Lang (Kaiser Foundation Health Plan Inc and Hospitals);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 11/13/2023
Location: Virtual
Subject: Alliance for Stronger FDA Webinar: Human Foods Program Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from industry, trade associations, academia, and media

Event Date: 11/14/2023
Location: Silver Spring, MD
Subject: Introductory Meeting; Produce Safety Issues of Mutual Interest
FDA Participant/Group: MARK MOORMAN; SAMIR ASSAR; CATHERINE MCDERMOTT; JAMES GORNY; GIRVIN LIGGANS; LARRY MORRIS;
Non FDA Participant/Group: Cathy Burns (International Fresh Produce Association);

Event Date: 11/15/2023
Location: Washington, DC
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: ANTHONY CATALINO;
Non FDA Participant/Group: Representative Diana DeGette (D-CO)

Event Date: 11/16/2023
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: JESSICA ROWDEN; REBECCA BUCKNER;
Non FDA Participant/Group: Monica Wilkins, Robert Ford (Abbott);

Event Date: 11/17/2023
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JESSICA ROWDEN; STEVEN MUSSER; KRISTI MULDOON JACOBS;
Non FDA Participant/Group: Stephanie M. Engel (University of North Carolina at Chapel Hill); Linda S. Birnbaum (Duke University); Russ Hauser (Harvard Medical School); Charlotte Brody (Healthy Babies, Bright Futures); Maureen Swanson (The Arc of the United States); Susan L. Schantz (University of Illinois at Urbana Champaign); Heather B. Patisaul (North Carolina State University); Ami Zota (Columbia University);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 11/16/2023
Location: Washington, DC
Subject: L'Oreal Women in Science Celebration
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering included members of Congress, government agencies, industry, and other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 11/13/2023
Location: Geneva, Switzerland
Subject: General Update Meeting
FDA Participant/Group: RUSSELL CAMPBELL, LEIGH VERBOIS, HARINDER CHAHAL, MICAH AUGUSMA
Non FDA Participant/Group: World Health Organization (WHO) Nutrition and Food Safety Team

Event Date: 11/13/2023
Location: Geneva, Switzerland
Subject: 12th Meeting of the World Health Organization (WHO) Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: RUSSELL CAMPBELL, LEIGH VERBOIS, HARINDER CHAHAL, MICAH AUGUSMA
Non FDA Participant/Group: Delegates to the World Health Organization (WHO) Member State Mechanism on Substandard and Falsified Medical Products

Event Date: 11/14/2023
Location: Geneva, Switzerland
Subject: African Network of Focal Points Preparatory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: African Delegation to the World Health Organization (WHO) Member State Mechanism on Substandard and Falsified Medical Products

Event Date: 11/14/2023
Location: Geneva, Switzerland
Subject: General Meeting Update
FDA Participant/Group: RUSSELL CAMPBELL, LEIGH VERBOIS, HARINDER CHAHAL, MICAH AUGUSMA
Non FDA Participant/Group: Brazil Delegation to the World Health Organization (WHO) Member State Mechanism on Substandard and Falsified Medical Products

Event Date: 11/15/2023
Location: Geneva, Switzerland
Subject: Departure Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Paul Huleatt (WHO Member State Mechanism on Substandard and Falsified Medical Products);

Official Name: Michael Rogers, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 11/13/2023
Location: Virtual
Subject: Interagency Advisory Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Advanced Research Projects Agency for Health (ARPA-H)

Event Date: 11/14/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Flagship Pioneering

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/14/2023
Location: Washington, DC
Subject: Duke Margolis Center for Health Policy; Panelist: Opportunities for Alignment on a Coordinated, Public-Private Strategy for Containing Respiratory Viruses
FDA Participant/Group: N/A
Non FDA Participant/Group: Health policy, public health, and government stakeholders

Event Date: 11/15/2023
Location: Virtual
Subject: Rare Diseases Workshop: Advancing Rare Disease Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the California Institute for Regenerative Medicine

Event Date: 11/15/2023
Location: Virtual
Subject: Biomanufacturing World Summit: Accelerating the Pace of Progress for Innovative Biologic Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 11/16/2023
Location: Virtual
Subject: Transformational Therapeutics Leadership Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and research stakeholders

Event Date: 11/17/2023
Location: Virtual
Subject: National Press Foundation Works Meeting: Gene Therapy and Genome Editing Technology
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Press Foundation

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 11/13/2023
Location: Virtual
Subject: FDA Actions on Probiotics
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff members from the American Association of Pediatrics (AAP)

Event Date: 11/14/2023
Location: Virtual
Subject: Food Safety and Inspection Service (FSIS) Charge on Genomics; FDA Charge on Cronobacter spp in Powered Infant Formula
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Various members of the National Advisory Committee on Microbiological Criteria for Foods (NACMCF)

Event Date: 11/15/2023
Location: College Park, MD
Subject: Nutrition Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Italian Ministry of Health

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 11/15/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Applied Research and Analysis Company (ARAC)

Event Date: 11/16/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the National Association of Tobacco Outlets (NATO)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

Event Date: 11/12/2023
Location: Orlando, FL
Subject: American College of Toxicology Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Regulatory agencies, academia, and industry

Official Name: Mark Raza, J.D., Chief Counsel

Event Date: 11/14/2023
Location: Silver Spring, MD
Subject: Electronic Nicotine Delivery Systems (ENDS) Civil Monetary Penalties (CMPs)
FDA Participant/Group: BRET KOPLOW; DAVID MEDNICK; SHANNON SINGLETON; JILL ATENCIO;
Non FDA Participant/Group: Trillium Chang, William B. Schultz (Zuckerman Spaeder LLP);